Agilent Technologies Drug discovery > Basic Research Products & Reviews

Product Filter

Field

See more

Technique

Search within technique

Company

Agilent Technologies

Ratings

25
Best match






SureSelect Target Enrichment System Kit

Agilent Technologies

Agilent's SureSelect market leading platform provides a complete portfolio of catalog and custom products, providing the flexibility you need, for your discovery to follow-up studies. Agilent™s SureSelect Target Enrichment System is a highly efficient hybrid selection technique for optimizing next-generation sequencing. It is available for the Illumina GA and HiSeq, Applied Biosystems SOLiD, and 454 Life Sciences FLX and GS J…

0.0/5.0
|0 Reviews




ABLE C Competent Cells

Agilent Technologies

The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. 

0.0/5.0
|0 Reviews


ABLE Competent Cell Kit

Agilent Technologies

The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. 

0.0/5.0
|0 Reviews











BacterioMatch II Electrocompetent Reporter Cells

Agilent Technologies

The exclusive BacterioMatch II two-hybrid system is an efficient method for detecting protein-protein interactions in vivo. The BacterioMatch II system offers the ability to screen libraries for harder-to-find binding partners with reduced background.  Fast results  Bacterial transformation - no new techniques to learn  Readily detect protein-protein interactions  Convenient dual reporter to validate putative positives…

0.0/5.0
|0 Reviews

BacterioMatch II Screening Reporter Competent Cells

Agilent Technologies

The exclusive BacterioMatch II two-hybrid system is an efficient method for detecting protein-protein interactions in vivo. The BacterioMatch II system offers the ability to screen libraries for harder-to-find binding partners with reduced background.  Fast results  Bacterial transformation - no new techniques to learn  Readily detect protein-protein interactions  Convenient dual reporter to validate putative positives…

0.0/5.0
|0 Reviews